Ben Adams

This discussion features Darren Incorvaia, a Staff writer at Fierce Biotech, who sheds light on how NIH funding cuts impact drug discovery. Fraser Kansteiner, a reporter/editor at Fierce Pharma, dives into the shifting dynamics within FDA vaccine policies. Angus Liu and Eric Sagonowsky provide insights on FDA leadership changes and their implications. The panel also evaluates the cautious optimism seen at the Jefferies Healthcare Conference, while Heather Landi and Paige Minemyer analyze the challenges providers face and the evolving role of AI in healthcare.